Navigating Tuberculosis: Insights into Host-Pathogen Protein Interactions: Foundations and Frontiers in Enzymology
Editat de Mohammad Shariq, Seyed Ehtesham Hasnain, Nasreen Zafar Ehteshamen Limba Engleză Paperback – 20 iun 2026
This comprehensive volume aims to advance knowledge and strategies to combat tuberculosis, aligning with the World Health Organization's goal of eradicating TB by 2035 by addressing the need for up-to-date information on host-pathogen interactions in tuberculosis and incorporating the latest research findings and advancements. It highlights emerging therapeutic targets among host and TB pathogen proteins and integrates multidisciplinary approaches from microbiology, immunology, and molecular biology, offering a holistic perspective on TB pathophysiology. Researchers will find detailed discussions on key host proteins involved in tuberculosis pathogenesis, the molecular tactics employed by M. tb to subvert host defenses, and host-mediated inhibition strategies targeting M. tb.
- Provides comprehensive insights into the complex interactions between host proteins and the tuberculosis pathogen, revealing essential aspects of tuberculosis pathophysiology
- Investigates the latest discoveries and breakthroughs in the field to uncover innovative approaches for diagnosing and treating tuberculosis, including novel therapeutic targets
- Offers a multidisciplinary perspective that combines insights from microbiology, immunology, biochemistry, and molecular biology
- Highlights cutting-edge research on key host and pathogen proteins involved in tuberculosis, offering detailed discussions on their roles in modulating innate and adaptive immunity
- Explores host-mediated inhibition strategies targeting Mycobacterium tuberculosis, paving the way for the development of novel therapeutic interventions to bolster host defenses against TB
Din seria Foundations and Frontiers in Enzymology
- 27%
Preț: 855.67 lei - 9%
Preț: 857.12 lei - 35%
Preț: 813.97 lei - 32%
Preț: 809.32 lei - 27%
Preț: 811.23 lei - 27%
Preț: 811.49 lei - 32%
Preț: 815.33 lei - 32%
Preț: 813.08 lei - 32%
Preț: 804.56 lei - 32%
Preț: 810.52 lei - 27%
Preț: 804.56 lei - 27%
Preț: 801.65 lei - 28%
Preț: 798.74 lei - 24%
Preț: 894.04 lei - 27%
Preț: 805.45 lei - 27%
Preț: 851.35 lei - 32%
Preț: 804.28 lei - 32%
Preț: 857.63 lei - nou
Preț: 829.27 lei - nou
Preț: 822.11 lei
Preț: 858.22 lei
Preț vechi: 903.38 lei
-5% Precomandă
Puncte Express: 1287
Preț estimativ în valută:
151.91€ • 177.48$ • 131.84£
151.91€ • 177.48$ • 131.84£
Carte nepublicată încă
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443277351
ISBN-10: 0443277354
Pagini: 325
Dimensiuni: 191 x 235 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
Seria Foundations and Frontiers in Enzymology
ISBN-10: 0443277354
Pagini: 325
Dimensiuni: 191 x 235 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
Seria Foundations and Frontiers in Enzymology
Cuprins
1. Mechanisms of Mycobacterium tuberculosis Virulence: The esx1 Locus and Host Countermeasures
2. Host Adaptation Strategies of Mycobacterium tuberculosis: A Molecular Perspective
3. Unravelling M. tuberculosis Manipulation of Host Immunity: Insights from Functional Genomics and Proteomics
4. Macrophages: Frontline Warriors Against Mycobacterium tuberculosis Invasion
5. Unravelling Mycobacterium tuberculosis Pathogenesis: Insights into PE/PPE Proteins from a Molecular Viewpoint
6. Host-Pathogen Dynamics in Mycobacterium tuberculosis: The Impact of PE/PPE Proteins on Innate and Adaptive Immunity
7. PE/PPE Proteins in Mycobacterium tuberculosis: Key Regulators of Apoptosis and Pathogenic Outcomes
8. Autophagy and Mycobacterium tuberculosis: Host Defense Mechanisms Versus Pathogen Evasion
9. Mechanisms of Phagosomal Damage Detection and Response to Mycobacterium tuberculosis: Repair, Autophagy, and Biogenesis
10. Programmed Cell Death During Mycobacterium tuberculosis Infection: The Roles of Pyroptosis and Necroptosis in Host Defense
11. Metabolic Repurposing in Mycobacterium-Infected Macrophages: A Strategy for Enhanced Virulence and Survival
12. Type I Interferons in Tuberculosis: Friend or Foe?
13. Type II Interferon in Tuberculosis: Orchestrating Infection Outcome through Mechanistic Insights
14. Cell Envelope Dynamics in Mycobacterium tuberculosis: Implications for Tuberculosis Pathogenesis and Host-Pathogen Interaction
15. Combatting Tuberculosis Drug Resistance: Effective Strategies for Overcoming Challenges
16. Beyond Treatment: Strategies for Mitigating Long-Term Morbidity and Mortality in Tuberculosis Survivors
2. Host Adaptation Strategies of Mycobacterium tuberculosis: A Molecular Perspective
3. Unravelling M. tuberculosis Manipulation of Host Immunity: Insights from Functional Genomics and Proteomics
4. Macrophages: Frontline Warriors Against Mycobacterium tuberculosis Invasion
5. Unravelling Mycobacterium tuberculosis Pathogenesis: Insights into PE/PPE Proteins from a Molecular Viewpoint
6. Host-Pathogen Dynamics in Mycobacterium tuberculosis: The Impact of PE/PPE Proteins on Innate and Adaptive Immunity
7. PE/PPE Proteins in Mycobacterium tuberculosis: Key Regulators of Apoptosis and Pathogenic Outcomes
8. Autophagy and Mycobacterium tuberculosis: Host Defense Mechanisms Versus Pathogen Evasion
9. Mechanisms of Phagosomal Damage Detection and Response to Mycobacterium tuberculosis: Repair, Autophagy, and Biogenesis
10. Programmed Cell Death During Mycobacterium tuberculosis Infection: The Roles of Pyroptosis and Necroptosis in Host Defense
11. Metabolic Repurposing in Mycobacterium-Infected Macrophages: A Strategy for Enhanced Virulence and Survival
12. Type I Interferons in Tuberculosis: Friend or Foe?
13. Type II Interferon in Tuberculosis: Orchestrating Infection Outcome through Mechanistic Insights
14. Cell Envelope Dynamics in Mycobacterium tuberculosis: Implications for Tuberculosis Pathogenesis and Host-Pathogen Interaction
15. Combatting Tuberculosis Drug Resistance: Effective Strategies for Overcoming Challenges
16. Beyond Treatment: Strategies for Mitigating Long-Term Morbidity and Mortality in Tuberculosis Survivors